Natural Product: NPC471923

Natural Product IDNPC471923
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
7-O-[(2,3,4-Tri-O-Acetyl)-A-Larabinopyranosyl)]Diphyllin
IUPAC Name [(3S,4S,5R,6S)-4,5-diacetyloxy-6-[[9-(1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3H-benzo[f][2]benzofuran-4-yl]oxy]oxan-3-yl] acetate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL3298730
PubChem CID 60200248
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001511] Lignan glycosides

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey BKJXLGUSQKIEGG-VLRDDJHDSA-N
Standard InCHI InChI=1S/C32H30O14/c1-14(33)43-25-12-40-32(30(45-16(3)35)29(25)44-15(2)34)46-28-19-10-23(38-5)22(37-4)9-18(19)26(27-20(28)11-39-31(27)36)17-6-7-21-24(8-17)42-13-41-21/h6-10,25,29-30,32H,11-13H2,1-5H3/t25-,29-,30+,32-/m0/s1
SMILES COc1cc2c(O[C@@H]3OC[C@@H]([C@@H]([C@H]3OC(=O)C)OC(=O)C)OC(=O)C)c3COC(=O)c3c(c2cc1OC)c1ccc2c(c1)OCO2

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   638.16 Volume:   602.115
?
Van der Waals volume.
Dense:   1.06 LogP:   2.436
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.635
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.163
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   11.0 Rigid Bonds:   35.0
TPSA:   160.58
?
Topological Polar Surface Area.
H-Bond Acceptor:   14.0
H-Bond Donor:   0.0 Rings:   6.0
Heavy Atoms:   14.0

MedChem Properties

QED Drug-Likeness Score:   0.261 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.265 Fsp3:   0.375
MCE-18:   122.773
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.929 Fluc inhibitor:   0.056
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.748
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.253
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.141 Promiscuous compounds:   0.637

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.349 MDCK Permeability:   -4.769
Pgp-inhibitor:   0.894 Pgp-substrate:   0.204
PAMPA:   0.532
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.009
20% Bioavailability (F20%):   0.036 30% Bioavailability (F30%):   0.003
50% Bioavailability (F50%):   0.915

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.016 MRP1:   0.99
Plasma Protein Binding (PPB):   96.827% Volume Distribution (VD):   -0.173
Fu: 3.504%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.288
BSEP inhibitor:   0.998

ADMET: Metabolism

CYP1A2-inhibitor:   0.823 CYP1A2-substrate:   0.002
CYP2C19-inhibitor:   0.897 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.038 CYP2C9-substrate:   0.977
CYP2D6-inhibitor:   0.179 CYP2D6-substrate:   0.648
CYP3A4-inhibitor:   0.068 CYP3A4-substrate:   0.031
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.502
HLM stability:   0.646
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  2.869 Half-life (T1/2):  1.05

ADMET: Toxicity

hERG Blockers:  0.063 hERG Blockers (10um):  0.312
Human Hepatotoxicity (H-HT):  0.971 Drug-induced Liver Injury (DILI):  0.999
AMES Toxicity:  0.984 Rat Oral Acute Toxicity:  0.343
Maximum Recommended Daily Dose:  0.467 Skin Sensitization:  1.0
Carcinogencity:  0.958 Eye Corrosion:  0.0
Eye Irritation:  0.01 Respiratory Toxicity:  0.01
Drug-induced Neurotoxicity:  0.659 Ototoxicity:  0.794
Hematotoxicity:  0.985 Drug-induced Nephrotoxicity:  0.991
Genotoxicity:  0.999 RPMI-8226 Immunitoxicity:  0.35
A549 Cytotoxicity:  0.749 Hek293 Cytotoxicity:  0.696
BCF:   0.916
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.762
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.522
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.933
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33442 phyllanthus poilanei Species n.a. Eukaryota n.a. n.a. n.a. PMID[24937209]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1044 Individual protein DNA topoisomerase II alpha Homo sapiens Activity = 2.7 % PMID[18232640]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell line HT-29 Homo sapiens IC50 = 110.0 nM PMID[17242150]
NPT139 Cell line HT-29 Homo sapiens IC50 = 140.0 nM PMID[29656990]
NPT377 Cell line OVCAR-3 Homo sapiens IC50 = 290.0 nM PMID[29656990]
NPT400 Cell line MDA-MB-435 Homo sapiens IC50 = 140.0 nM PMID[29656990]
NPT82 Cell line MDA-MB-231 Homo sapiens IC50 = 1000.0 nM PMID[29656990]
NPT111 Cell line K562 Homo sapiens IC50 = 850.0 nM PMID[29656990]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC471923 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8675 High Similarity NPC473697
0.8125 Intermediate Similarity NPC473531
0.7442 Intermediate Similarity NPC471920
0.7097 Intermediate Similarity NPC275690
0.6977 Remote Similarity NPC20114
0.6932 Remote Similarity NPC471922
0.6818 Remote Similarity NPC471921
0.6667 Remote Similarity NPC239113
0.6566 Remote Similarity NPC161609
0.6556 Remote Similarity NPC292712
0.6447 Remote Similarity NPC19600
0.6437 Remote Similarity NPC474075
0.6437 Remote Similarity NPC483381
0.6364 Remote Similarity NPC184624
0.6292 Remote Similarity NPC114550
0.6292 Remote Similarity NPC312006
0.6292 Remote Similarity NPC602979
0.6044 Remote Similarity NPC129930
0.6026 Remote Similarity NPC115123
0.602 Remote Similarity NPC35266
0.602 Remote Similarity NPC167045
0.602 Remote Similarity NPC114120
0.5556 Remote Similarity NPC78944
0.5366 Remote Similarity NPC15212
0.5268 Remote Similarity NPC286301
0.5268 Remote Similarity NPC313063

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471923 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data